Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From NeuroNova AB
Medical Device Deals Update, March 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced February-March 2014.
Deals Shaping The Medical Industry, March 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced January through February 2014.
Safinamide's MOTION could help Newron/Zambon SETTLE on PD market
Further to a pledge to expedite global filings for the Parkinson's disease (PD) compound safinamide, Newron Pharmaceuticals and its partner Zambon say regulatory submissions are expected in the US and EU in the fourth quarter, for the use of the drug both an add-on therapy to dopamine agonist therapy in patients with early PD and as an add-on to levodopa therapy in patients with advanced PD.
DEALS ROUND-UP: M&A and partnering 1-28 December
As companies flurried to clinch deals by the end of the year, a number of significant agreements were signed or completed last December.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.